จุฬาลงกรณ์มหาวิทยาลัย

Scientists from Chulalongkorn University are studying a new treatment for breast cancer called CAR T-cell therapy. They have created CAR T-cells that target a specific antigen called mucin-1 (MUC1)...

A team of researchers from Chulalongkorn University has developed a highly efficient hybridoma generation and screening strategy to generate high-potency chimeric anti-PD-1 molecules, a protein that plays a significant...